ArticleFrontiers in neurology2025

Cladribine tablets as therapy for advanced relapsing-remitting multiple sclerosis: a 4-year follow-up real-world, multi-center, retrospective, cohort study.

Aleksandra Pogoda-Wesołowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.